In breast cancer, SHMT2 upregulation leads to an increased concentration of nicotinamide adenine dinucleotide phosphate (NADPH) and improves redox balance, which in turn facilitates cancer cell growth under hypoxic conditions 9. The gene discussed is SHMT2; the disease is breast carcinoma.